Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ed J Kuijper

Showing results (201-210 of 250) with videos related to

Pageof 25
Sort By:
The Lancet. Infectious Diseases|December 4, 2020
Periodic screening of donor faeces with a quarantine period to prevent transmission of multidrug-resistant organisms during faecal microbiota transplantation: a retrospective cohort studyKaruna E W Vendrik, Elisabeth M Terveer, Ed J Kuijper, et al.
Frontiers in Cellular and Infection Microbiology|November 17, 2022
2'-Fucosyllactose inhibits proliferation of <i>Clostridioides difficile</i> ATCC 43599 in the CDi-screen, an <i>in vitro</i> model simulating <i>Clostridioides difficile</i> infectionMaria Wiese, Frank H J Schuren, Wiep Klaas Smits, et al.
The Lancet. Microbe|June 6, 2022
Gut colonisation by extended-spectrum β-lactamase-producing Escherichia coli and its association with the gut microbiome and metabolome in Dutch adults: a matched case-control studyQuinten R Ducarmon, Romy D Zwittink, Roel P J Willems, et al.
Scientific Reports|May 27, 2018
Proteomic identification of Axc, a novel beta-lactamase with carbapenemase activity in a meropenem-resistant clinical isolate of Achromobacter xylosoxidansFrank Fleurbaaij, Alex A Henneman, Jeroen Corver, et al.
Genome Medicine|April 8, 2021
Microbiota-associated risk factors for asymptomatic gut colonisation with multi-drug-resistant organisms in a Dutch nursing homeQuinten R Ducarmon, Elisabeth M Terveer, Sam Nooij, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 5, 2007
An outbreak of Pneumocystis jiroveci pneumonia with 1 predominant genotype among renal transplant recipients: interhuman transmission or a common environmental source?Mark G J de Boer, Lesla E S Bruijnesteijn van Coppenraet, Andre Gaasbeek, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|March 31, 2005
Peritoneal dialysis-related infections recommendations: 2005 updateBeth Piraino, George R Bailie, Judith Bernardini, et al.
Molecular & Cellular Proteomics : MCP|March 14, 2014
A novel secreted metalloprotease (CD2830) from Clostridium difficile cleaves specific proline sequences in LPXTG cell surface proteinsPaul J Hensbergen, Oleg I Klychnikov, Dennis Bakker, et al.
United European Gastroenterology Journal|December 17, 2019
Stool for fecal microbiota transplantation should be classified as a transplant product and not as a drugJosbert J Keller, Maria Jgt Vehreschild, Christian L Hvas, et al.
United European Gastroenterology Journal|March 28, 2020
Donated stool for faecal microbiota transplantation is not a drug, but guidance and regulation are neededJosbert J Keller, Maria Jgt Vehreschild, Christian L Hvas, et al.
Pageof 25

Showing results (201-210 of 250) with videos related to

Sort By:
Pageof 25
The Lancet. Infectious Diseases|December 4, 2020
Periodic screening of donor faeces with a quarantine period to prevent transmission of multidrug-resistant organisms during faecal microbiota transplantation: a retrospective cohort studyKaruna E W Vendrik, Elisabeth M Terveer, Ed J Kuijper, et al.
Frontiers in Cellular and Infection Microbiology|November 17, 2022
2'-Fucosyllactose inhibits proliferation of <i>Clostridioides difficile</i> ATCC 43599 in the CDi-screen, an <i>in vitro</i> model simulating <i>Clostridioides difficile</i> infectionMaria Wiese, Frank H J Schuren, Wiep Klaas Smits, et al.
The Lancet. Microbe|June 6, 2022
Gut colonisation by extended-spectrum β-lactamase-producing Escherichia coli and its association with the gut microbiome and metabolome in Dutch adults: a matched case-control studyQuinten R Ducarmon, Romy D Zwittink, Roel P J Willems, et al.
Scientific Reports|May 27, 2018
Proteomic identification of Axc, a novel beta-lactamase with carbapenemase activity in a meropenem-resistant clinical isolate of Achromobacter xylosoxidansFrank Fleurbaaij, Alex A Henneman, Jeroen Corver, et al.
Genome Medicine|April 8, 2021
Microbiota-associated risk factors for asymptomatic gut colonisation with multi-drug-resistant organisms in a Dutch nursing homeQuinten R Ducarmon, Elisabeth M Terveer, Sam Nooij, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|April 5, 2007
An outbreak of Pneumocystis jiroveci pneumonia with 1 predominant genotype among renal transplant recipients: interhuman transmission or a common environmental source?Mark G J de Boer, Lesla E S Bruijnesteijn van Coppenraet, Andre Gaasbeek, et al.
Peritoneal Dialysis International : Journal of the International Society for Peritoneal Dialysis|March 31, 2005
Peritoneal dialysis-related infections recommendations: 2005 updateBeth Piraino, George R Bailie, Judith Bernardini, et al.
Molecular & Cellular Proteomics : MCP|March 14, 2014
A novel secreted metalloprotease (CD2830) from Clostridium difficile cleaves specific proline sequences in LPXTG cell surface proteinsPaul J Hensbergen, Oleg I Klychnikov, Dennis Bakker, et al.
United European Gastroenterology Journal|December 17, 2019
Stool for fecal microbiota transplantation should be classified as a transplant product and not as a drugJosbert J Keller, Maria Jgt Vehreschild, Christian L Hvas, et al.
United European Gastroenterology Journal|March 28, 2020
Donated stool for faecal microbiota transplantation is not a drug, but guidance and regulation are neededJosbert J Keller, Maria Jgt Vehreschild, Christian L Hvas, et al.
Pageof 25